Back to Search
Start Over
Second Line Treatment with Bruton Tyrosine Kinase Inhibitor (BTKi) or Bcl-2 Inhibitor (Bcl-2i) in Patients with Chronic Lymphocytic Leukemia (CLL): Primary Analysis of the Czech Study Group for CLL (CSCLL)
- Source :
- Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p6542-6542, 1p
- Publication Year :
- 2023
-
Abstract
- Introduction:
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 142
- Issue :
- 1, Number 1 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs64706812
- Full Text :
- https://doi.org/10.1182/blood-2023-181249